Association of Intronic C>T Single Nucleotide Polymorphism (rs782440) with Borderline Personality Disorder: A Case-Control Study

Overview

Journal Cell J

Specialty Cell Biology

Date 2023 Dec 10

PMID 38071410

Authors

Nazanin Hatami Bavarsad

Leila Jahangard

Masood Saidijam

Seyed Asaad Karimi

Ali Reza Soltanian

Elahe Shahriari

Saeid Afshar

Abdolrahman Sarihi

Affiliations

Soon will be listed here.

Abstract

Objective: From the perspective of etiology, borderline personality disorder (BPD) is a multifactorial and complex disorder, hence our understanding about the molecular basis and signaling of this disorder is extremely limited. The purpose of this study was evaluating the relationship between BPD and the Monoacylglycerol lipase polymorphism rs782440 in the population of Hamadan, Iran.

Materials And Methods: In this case-control study, 106 participants including 53 patients with BPD and 53 healthy control subjects were selected by psychiatrists in the Department of Psychiatry at Farshchian Sina Hospital in Hamadan. The BPD patients were selected based on the Diagnostic and Statistical Manual of Mental Disorders form for diagnosing BPD patients. For genotyping, polymerase chain reaction (PCR) was used to amplify the desired region including the intronic C>T single nucleotide polymorphism (SNP) (rs782440) and afterward the amplicon was sequenced using the Sanger sequencing method. To determine the genotype of these patients, their sequences were aligned with the reference sequence of MGLL through the CLC genomic workbench software.

Results: The results indicated that the frequency of TT in comparison to the CC genotype was significantly different (P=0.003) and the risk of BPD in change from the TT genotype to CC genotype was increased by 6.679%. Regarding the frequency of allele in this group, no significant difference was observed.

Conclusion: This paper, has studied and reports for the first time, the association between SNP (rs782440) with BPD. The findings of the current research revealed that the TT genotype increases the risk of BPD compared to the CC genotype. Considering the lack of a suitable diagnostic biomarker for BPD, using this potential biomarker in the near future can be promising.

References

Kaplan B, Gulec M, Gica S, Gulec H . The association between neurocognitive functioning and clinical features of borderline personality disorder. Braz J Psychiatry. 2020; 42(5):503-509. PMC: 7524408. DOI: 10.1590/1516-4446-2019-0752. View

Kolla N, Meyer J, Sanches M, Charbonneau J . Monoamine Oxidase-A Genetic Variants and Childhood Abuse Predict Impulsiveness in Borderline Personality Disorder. Clin Psychopharmacol Neurosci. 2017; 15(4):343-351. PMC: 5678484. DOI: 10.9758/cpn.2017.15.4.343. View

Wang Y, Gu N, Duan T, Kesner P, Blaskovits F, Liu J . Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses. Mol Psychiatry. 2016; 22(2):215-226. PMC: 5285470. DOI: 10.1038/mp.2016.22. View

Harismendy O, Bansal V, Bhatia G, Nakano M, Scott M, Wang X . Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level. Genome Biol. 2010; 11(11):R118. PMC: 3156957. DOI: 10.1186/gb-2010-11-11-r118. View

Zanarini M, Frankenburg F, Reich D, Conkey L, Fitzmaurice G . Treatment rates for patients with borderline personality disorder and other personality disorders: a 16-year study. Psychiatr Serv. 2014; 66(1):15-20. PMC: 4283568. DOI: 10.1176/appi.ps.201400055. View

Izzo N, Yuede C, LaBarbera K, Limegrover C, Rehak C, Yurko R . Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification. Alzheimers Dement. 2021; 17(8):1365-1382. PMC: 8349378. DOI: 10.1002/alz.12302. View

Hohmann A . Inhibitors of monoacylglycerol lipase as novel analgesics. Br J Pharmacol. 2007; 150(6):673-5. PMC: 2013872. DOI: 10.1038/sj.bjp.0707153. View

Joyce P, Stephenson J, Kennedy M, Mulder R, McHugh P . The presence of both serotonin 1A receptor (HTR1A) and dopamine transporter (DAT1) gene variants increase the risk of borderline personality disorder. Front Genet. 2014; 4:313. PMC: 3882668. DOI: 10.3389/fgene.2013.00313. View

Tagliamonte S, Laiola M, Ferracane R, Vitale M, Gallo M, Meslier V . Mediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammation. Eur J Nutr. 2021; 60(7):3703-3716. PMC: 8437855. DOI: 10.1007/s00394-021-02538-8. View

10.

Palmer R, McGeary J, Knopik V, Bidwell L, Metrik J . and variation and affective states induced by marijuana smoking. Am J Drug Alcohol Abuse. 2019; 45(5):514-526. PMC: 6931041. DOI: 10.1080/00952990.2019.1614596. View

11.

Bhatia G, Bansal V, Harismendy O, Schork N, Topol E, Frazer K . A covering method for detecting genetic associations between rare variants and common phenotypes. PLoS Comput Biol. 2010; 6(10):e1000954. PMC: 2954823. DOI: 10.1371/journal.pcbi.1000954. View

12.

Ogawa S, Kunugi H . Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants. Curr Neuropharmacol. 2015; 13(6):760-75. PMC: 4759315. DOI: 10.2174/1570159x13666150612225212. View

13.

Chanen A, Betts J, Jackson H, Cotton S, Gleeson J, Davey C . A Comparison of Adolescent versus Young Adult Outpatients with First-Presentation Borderline Personality Disorder: Findings from the MOBY Randomized Controlled Trial. Can J Psychiatry. 2021; 67(1):26-38. PMC: 8811246. DOI: 10.1177/0706743721992677. View

14.

Lubke G, Laurin C, Amin N, Hottenga J, Willemsen G, van Grootheest G . Genome-wide analyses of borderline personality features. Mol Psychiatry. 2013; 19(8):923-9. PMC: 3872258. DOI: 10.1038/mp.2013.109. View

15.

Ando T, Tamura N, Mera T, Morita C, Takei M, Nakamoto C . Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese population. Mol Genet Genomic Med. 2014; 2(4):313-8. PMC: 4113271. DOI: 10.1002/mgg3.69. View

16.

Tardelli M . Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease. World J Gastroenterol. 2020; 26(25):3577-3585. PMC: 7366061. DOI: 10.3748/wjg.v26.i25.3577. View

17.

Aliczki M, Varga Z, Balogh Z, Haller J . Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice. Psychopharmacology (Berl). 2014; 232(12):2157-67. DOI: 10.1007/s00213-014-3846-1. View

18.

Zhang M, Liu N, Chen H, Zhang N . Oxytocin receptor gene, childhood maltreatment and borderline personality disorder features among male inmates in China. BMC Psychiatry. 2020; 20(1):332. PMC: 7315490. DOI: 10.1186/s12888-020-02710-0. View

19.

Lazary J, Eszlari N, Juhasz G, Bagdy G . A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes. J Affect Disord. 2019; 257:716-722. DOI: 10.1016/j.jad.2019.07.083. View

20.

Wong B, Camilleri M, Busciglio I, Carlson P, Szarka L, Burton D . Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome. Gastroenterology. 2011; 141(5):1638-47.e1-7. PMC: 3202649. DOI: 10.1053/j.gastro.2011.07.036. View